Business News • PR NewsWire • Cytovation raises $20 million in Series A financing round to advance clinical development of CyPep-1, a first-in-class targeted tumor membrane immunotherapy

Cytovation raises $20 million in Series A financing round to advance clinical development of CyPep-1, a first-in-class targeted tumor membrane immunotherapy

Cytovation raises $20 million in Series A financing round to advance clinical development of CyPep-1, a first-in-class targeted tumor membrane immunotherapy

BERGEN, Norway, Jan. 25, 2022 /PRNewswire/ -- Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumor membrane immunotherapy, announces the successful closing of its Series A financing round, raising a total of NOK 180...

View More : https://www.prnewswire.com:443/news-releases/cytovation-raises-20-million-in-series-a-financing-round-to-advance-clinica...

Releted News by prnewswire

Conditional Access System Market to Grow by USD 779.65 Million | Market Research Insights Highlight Increased Worldwide Adoption of Satellite TV as Key Driver | Technavio

Bahrain's CoinMENA obtains second cryptocurrency license from European Union paving the way for expansion to new jurisdictions